Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin

British Journal of Clinical Pharmacology

Volumn 71, Issue 2, 2011, Pages 297-300

  Wendland, Thomas ^a   Daubner, Barbara ^b   Pichler, Werner J ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b ADR AC GmbH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CEFTOBIPROLE; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; MEROPENEM; METOPROLOL; PERINDOPRIL; PREDNISOLONE; RIFAMPICIN; VANCOMYCIN;

AGED; AGRANULOCYTOSIS; CASE REPORT; CLINICAL FEATURE; DRESS SYNDROME; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; ENDOCARDITIS; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPEREOSINOPHILIA; LETTER; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; OSTEOMYELITIS; PRIORITY JOURNAL; SYMPTOM;

AGED; AGRANULOCYTOSIS; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; EOSINOPHILIA; FEMALE; HUMANS; RIFAMPIN; SYNDROME; VANCOMYCIN;

EID: 78650991650     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03832.x     Document Type: Letter

References (21)

1. Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 1950; 242: 897-8.
2. Ben m'rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, Guesmi M, Rollot F, Dehoux M, Guillevin L, Moachon L. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 2009; 88: 131-40.
3. Naisbitt DJ, Farrell J, Wong G, Depta JP, Dodd CC, Hopkins JE, Gibney CA, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 2003; 111: 1393-403.
4. Barbour A, Schmidt S, Rand KH, Derendorf H. Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2009; 34: 1-7.
5. Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin Infect Dis 2008; 46: 647-55.
6. TM. Product monograph. In: Arzneimittelkompendium der Schweiz. Basel: Documed, 2010.
7. Olaison L, Belin L, Hogevik H, Alestig K. Incidence of beta-lactam-induced delayed hypersensitivity and neutropenia during treatment of infective endocarditis. Arch Intern Med 1999; 159: 607-15.
8. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59: 809-20.
9. Tesfa D, Keisu M, Palmblad J. Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management. Am J Hematol 2009; 84: 428-34.
10. Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2007; 146: 657-65.
11. Uetrecht JP. Reactive metabolites and agranulocytosis. Eur J Haematol Suppl 1996; 60: 83-8.
12. Kindmark A, Jawaid A, Harbron CG, Barratt BJ, Bengtsson OF, Andersson TB, Carlsson S, Cederbrant KE, Gibson NJ, Armstrong M, Lagerström-Fermér ME, Dellsén A, Brown EM, Thornton M, Dukes C, Jenkins SC, Firth MA, Harrod GO, Pinel TH, Billing-Clason SM, Cardon LR, March RE. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J 2008; 8: 186-95.
13. Bower M, McCall-Peat N, Ryan N, Davies L, Young AM, Gupta S, Nelson M, Gazzard B, Stebbing J. Protease inhibitors potentiate chemotherapy-induced neutropenia. Blood 2004; 104: 2943-6.
14. Coleman MD. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology 2001; 162: 53-60.
15. Lee D, Dewdney JM, Edwards RG, Neftel KA, Wälti M. Measurement of specific IgG antibody levels in serum of patients on regimes comprising high total dose beta-lactam therapy. Int Arch Allergy Appl Immunol 1986; 79: 344-8.
16. Murphy MF, Metcalfe P, Grint PC, Green AR, Knowles S, Amess JA, Waters AH. Cephalosporin-induced immune neutropenia. Br J Haematol 1985; 59: 9-14.
17. Peralta G, Sanchez-Santiago MB. [Beta-lactam-induced neutropenia. An old forgotten companion]. Enferm Infecc Microbiol Clin 2005; 23: 485-91.
18. Wu Y, Farrell J, Pirmohamed M, Park BK, Naisbitt DJ. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity. J Allergy Clin Immunol 2007; 119: 973-81.
19. Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009; 29: 481-501.
20. Mennicke M, Zawodniak A, Keller M, Wilkens L, Yawalkar N, Stickel F, Keogh A, Inderbitzin D, Candinas D, Pichler WJ. Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant 2009; 9: 2197-202.
21. Pichler WJ. Drug hypersenstivity reactions: classifications and relationship to T-cell activation. In: Drug Hypersensitivity, ed. Pichler WJ. Basel: Karger, 2007; 168-89.